Common Contracts

AGREEMENT AND PLAN OF MERGER among: TURNING POINT THERAPEUTICS, INC., a Delaware corporation; BRISTOL-MYERS SQUIBB COMPANY, a Delaware corporation; and RHUMBA MERGER SUB INC., a Delaware corporation Dated as of June 2, 2022

Agreement and Plan of Merger • June 3rd, 2022 • Turning Point Therapeutics, Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Agreement and Plan of Merger
• Filed
  June 3rd, 2022
• Company
  Turning Point Therapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

THIS AGREEMENT AND PLAN OF MERGER is made and entered into as of June 2, 2022, by and among: BRISTOL-MYERS SQUIBB COMPANY, a Delaware corporation (“Parent”); RHUMBA MERGER SUB INC., a Delaware corporation and a wholly owned subsidiary of Parent (“Purchaser”); and TURNING POINT THERAPEUTICS, INC., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.

AGREEMENT AND PLAN OF MERGER among: SENOMYX, INC., a Delaware corporation; FIRMENICH INCORPORATED, a Delaware corporation; and SENTRY MERGER SUB, INC., a Delaware corporation Dated as of September 16, 2018

Agreement and Plan of Merger • September 17th, 2018 • Senomyx Inc • Services-commercial physical & biological research • Delaware

• Contract Type
  Agreement and Plan of Merger
• Filed
  September 17th, 2018
• Company
  Senomyx Inc
• Industry
  Services-commercial physical & biological research
• Jurisdiction
  Delaware

THIS AGREEMENT AND PLAN OF MERGER (“Agreement”) is made and entered into as of September 16, 2018, by and among: FIRMENICH INCORPORATED, a Delaware corporation (“Parent”); SENTRY MERGER SUB, INC., a Delaware corporation and a wholly owned subsidiary of Parent (“Purchaser”); and SENOMYX, INC., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.